AI News, Fujitsu Improves Efficiency in Cancer Genomic Medicine in Joint AI ... artificial intelligence

To stop a tech apocalypse we need ethics and the arts

If recent television shows are anything to go by, we're a little concerned about the consequences of technological development.

recent report from the Australian Council of Learned Academies (ACOLA) brought together experts from scientific and technical fields as well as the humanities, arts and social sciences to examine key issues arising from artificial intelligence.

The institute brings together researchers from the humanities, education, law, medicine, business and STEM to study and develop 'human-centered' AI technologies.

The founder of the institute, philosopher Nick Bostrom, said: 'There is a long-distance race on between humanity's technological capability, which is like a stallion galloping across the fields, and humanity's wisdom, which is more like a foal on unsteady legs.'

Microsoft's Brad Smith and Harry Shum wrote in their 2018 book The Future Computed that one of their 'most important conclusions' was that the humanities and social sciences have a crucial role to play in confronting the challenges raised by AI: 'Languages, art, history, economics, ethics, philosophy, psychology and human development courses can teach critical, philosophical and ethics-based skills that will be instrumental in the development and management of AI solutions.

In a TED talk on 'Why tech needs the humanities,' Eric Berridge—chief executive of the IBM-owned tech consulting firm Bluewolf—explains why his company increasingly hires humanities graduates.'

Education for a brighter future Similarly, Matt Reaney, the chief executive and founder of Big Cloud—a recruitment company that specializes in data science, machine learning and AI employment—has argued that technology needs more people with humanities training.

Critical thinking skills, deeper understanding of the world around us, philosophy, ethics, communication, and creativity offer different approaches to problems posed by technology.'

He has argued that in the age of AI, higher education should be focusing on what he calls 'humanics,' equipping graduates with three key literacies: technological literacy, data literacy and human literacy.

The time has come to answer the call for humanities graduates capable of crossing over into the world of technology so that our human future can be as bright as possible.

Fujitsu : Laboratories and Aichi Cancer Center in Japan Sign Comprehensive Joint Research Agreement to Drive Advances in Cancer Genomic Medicine with AI Technology

and Aichi Cancer Center(1) have successfully concluded a comprehensive cooperative research agreement to leverage newly developed AI technology to improve the efficiency of cancer genome information analysis and contribute to advances in the field of cancer genomic medicine(2).

The joint research, which builds on Fujitsu Laboratories' recent collaborative efforts with the Institute of Medical Science at the University of Tokyo and AI technologies cultivated by Fujitsu Laboratories(3), will draw on knowledge and issues identified through the research and clinical studies of cancer genome medical care at Aichi Cancer Center, as well as large-scale genomic data and medical records held by the Center.

In the emergent field of genomic cancer medicine, a board of molecular tumor specialists interprets the results of a patient's cancer gene profile to formulate appropriate treatment plans based on their unique circumstances.

This process remains very time consuming, however, proving a challenge for the Aichi Cancer Center and other institutions engaged in this field-as the number of genetic tests increases, the burden on doctors, who must interpret results on an individual basis, continues to mount.

To address this challenge, Fujitsu Laboratories and Aichi Cancer Center intend to create a new AI technology to improve the viability of cancer genomic medicine, drawing on technology initially developed by Fujitsu Laboratories in a joint research project with the Institute of Medical Science at the University of Tokyo.

The new technology will be developed using aggregated data for genomic and clinical profiles mainly for solid cancers held in trust by the Aichi Cancer Center, with the main purpose of improving the efficiency of interpreting the results of comprehensive genomic analyses.

In addition, cancer genome data for various cases collected from patients at hospitals will be registered in a common reference database, which will be continuously expanded to develop integrated functions that enable more comprehensive and reliable selection of anti-cancer drugs.

form of treatment for cancer based on genomic alterations/profiles, which offers medical professionals more effective treatment plans using of therapeutic drugs selected based on genomic variants/profiles to deliver 'precision medicine,' tailored to individual patients [3]The joint research, which builds on Fujitsu's recent collaborative efforts with the Institute of Medical Science at the University of Tokyo and AI technologies cultivated by Fujitsu Laboratories In a joint research project with the Institute of Medical Science at the University of Tokyo, Fujitsu Laboratories Ltd.